Further Clarification on news item

| Updated on January 18, 2016 Published on January 18, 2016

With reference to the news flashed on ET NOW, January 13, 2016 - "Marksans Pharma Goa plant get notification of deficiency in GMP from UK MHRA. 40% of Marksans Pharma revenue comes from UK", Marksans Pharma Ltd has submitted to BSE a copy of further Clarification is enclosed.

Pdf Link: >Further Clarification on news item

Source : BSE - >www.bseindia.com

Published on January 18, 2016
This article is closed for comments.
Please Email the Editor